Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Operating Grant: COVID-19 - Project Grant

University of Calgary

$248,625.00

Impact of Aerosol Box Use on Patterns of Healthcare Provider and Environmental Contamination during Aerosol Generating Medical Procedures: A Multicenter Study

FY 2020-21

Summary
Many patients diagnosed with Coronavirus Disease 2019, or COVID-19, suffer from severe illness requiring intensive medical care. The sickest patients often require procedures, called aerosol-generating medical procedures (AGMPs), that spread virus throughout the air. When doctors perform these procedures they are at high risk of getting sick with COVID-19. A new device, called an aerosol box, has been invented to protect healthcare providers while they perform AGMPs. This device is placed over top of the patient's head while they are lying on a stretcher, shielding the doctor's face from viruses in the air. Unfortunately, there has been no research done describing how well the aerosol box works to protect doctors, nurses and respiratory therapists. Our study will use a plastic manikin head and chest as a patient. Teams of doctors, nurses and respiratory therapists will work together to perform AGMPs on this manikin. We will put a special powder in the manikin's mouth. When the doctor's perform their task, the powder will be spread throughout the air, just like a virus. Then we will use a camera and UV light to see where the powder has spread. Half of the teams will use the aerosol box, and the other half will not, which will allow us to determine if it is effective at preventing spread. By seeing where the powder has spread, we will also be able to figure out how risky each type of AGMP is for doctors, nurses and respiratory therapists. At the same time, we will measure how long it takes for them to complete the procedure. This is important because it will help hospitals decide if aerosol boxes should be routinely used when caring for COVID-19 patients. Our study will also help hospitals develop rules to reduce healthcare provider risk when performing AGMPs during the COVID-19 pandemic.
Program
Operating Grant: COVID-19 - Project Grant
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
442981
Name
Cheng Adam
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Human Development, Child and Youth Health
Theme2
Health systems / services
Prcname2
Special Cases
Projecttitle
Impact of Aerosol Box Use on Patterns of Healthcare Provider and Environmental Contamination during Aerosol Generating Medical Procedures: A Multicenter Study
Programtype2
Operating Grants
Orgnameinp2
University of Calgary
Cihramount2
$248,625
Cihrequipment2
$0
Programname2
Operating Grant: COVID-19 - Project Grant
Keyworddelim
Aerosol Generating Medical Procedures; Aerosolization; Contamination; Covid-19; Infection Control; Nosocomial Infection; Personal Protective Equipment; Sars-Cov-2
Abstract
Many patients diagnosed with Coronavirus Disease 2019, or COVID-19, suffer from severe illness requiring intensive medical care. The sickest patients often require procedures, called aerosol-generating medical procedures (AGMPs), that spread virus throughout the air. When doctors perform these procedures they are at high risk of getting sick with COVID-19. A new device, called an aerosol box, has been invented to protect healthcare providers while they perform AGMPs. This device is placed over top of the patient's head while they are lying on a stretcher, shielding the doctor's face from viruses in the air. Unfortunately, there has been no research done describing how well the aerosol box works to protect doctors, nurses and respiratory therapists. Our study will use a plastic manikin head and chest as a patient. Teams of doctors, nurses and respiratory therapists will work together to perform AGMPs on this manikin. We will put a special powder in the manikin's mouth. When the doctor's perform their task, the powder will be spread throughout the air, just like a virus. Then we will use a camera and UV light to see where the powder has spread. Half of the teams will use the aerosol box, and the other half will not, which will allow us to determine if it is effective at preventing spread. By seeing where the powder has spread, we will also be able to figure out how risky each type of AGMP is for doctors, nurses and respiratory therapists. At the same time, we will measure how long it takes for them to complete the procedure. This is important because it will help hospitals decide if aerosol boxes should be routinely used when caring for COVID-19 patients. Our study will also help hospitals develop rules to reduce healthcare provider risk when performing AGMPs during the COVID-19 pandemic.
Competitiondate
202011
Approvedterm2
1 yr 6 mths
Pinamesdelim
Cheng, Adam
Approvedterm
1 an 6 mois
Cihrcontribution2
~ $248,625~ $0~
University of Calgary - $248,625 Grant (2020-21) | Canada Spends